Ifrah Financial Services Inc. Cuts Holdings in UnitedHealth Group Inc (NYSE:UNH)

Ifrah Financial Services Inc. cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,043 shares of the healthcare conglomerate’s stock after selling 74 shares during the quarter. Ifrah Financial Services Inc.’s holdings in UnitedHealth Group were worth $1,483,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Tobias Financial Advisors Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at about $29,000. Selective Wealth Management Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $27,000. CXI Advisors bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $38,000. Delta Asset Management LLC TN grew its holdings in shares of UnitedHealth Group by 111.0% during the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 81 shares during the last quarter. Finally, Fusion Family Wealth LLC grew its holdings in shares of UnitedHealth Group by 329.7% during the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 122 shares during the last quarter. Institutional investors and hedge funds own 85.81% of the company’s stock.

In other news, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $272.77, for a total value of $2,018,498.00. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Thursday, January 16th. The stock was sold at an average price of $299.45, for a total transaction of $4,491,750.00. Following the completion of the transaction, the director now directly owns 158,598 shares in the company, valued at approximately $47,492,171.10. The disclosure for this sale can be found here. 0.82% of the stock is owned by insiders.

NYSE:UNH traded down $0.32 on Friday, reaching $301.88. 40,299 shares of the stock traded hands, compared to its average volume of 4,099,015. The company has a market capitalization of $271.94 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 1.41 and a beta of 0.69. The company has a current ratio of 0.69, a quick ratio of 0.70 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $305.90. The company’s fifty day simple moving average is $291.30 and its 200 day simple moving average is $260.18.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 EPS for the quarter, topping analysts’ consensus estimates of $3.77 by $0.13. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The firm had revenue of $60.90 billion during the quarter, compared to analyst estimates of $61.17 billion. During the same period in the previous year, the business posted $3.28 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Inc will post 16.47 EPS for the current fiscal year.

UNH has been the topic of several recent research reports. Morgan Stanley reaffirmed a “buy” rating and set a $312.00 target price (up previously from $294.00) on shares of UnitedHealth Group in a report on Friday, November 22nd. Credit Suisse Group increased their price target on shares of UnitedHealth Group from $320.00 to $330.00 and gave the company an “outperform” rating in a research report on Wednesday, January 8th. Citigroup increased their price target on shares of UnitedHealth Group from $286.00 to $346.00 and gave the company a “buy” rating in a research report on Thursday, January 16th. Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $315.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, January 16th. Finally, Barclays reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Sunday, January 19th. Five investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $313.50.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What are the benefits of investing in REITs?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.